Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
Rhea-AI Summary
MDxHealth SA (NASDAQ: MDXH) has announced it will release its Q4 and full year 2024 financial results after market close on February 26, 2025. The company will host a conference call and webcast at 4:30pm ET / 22:30 CET on the same day.
The conference call will feature CEO Michael K. McGarrity and CFO Ron Kalfus, with dial-in numbers provided for the United States, Belgium, The Netherlands, and the United Kingdom. A webcast replay will be available on the company's website following the live call.
Positive
- None.
Negative
- None.
News Market Reaction – MDXH
On the day this news was published, MDXH gained 0.55%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2024, after market close on Wednesday, February 26, 2025.
| Title: | Mdxhealth Presents Fourth Quarter and Full Year 2024 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | February 26, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10196702 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1706814&tp_key=e01537d9e2 |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR) US: +1 949 271 9223 ir@mdxhealth.com |
FAQ
When will MDxHealth (MDXH) release its Q4 and full year 2024 financial results?
What time is MDxHealth's (MDXH) Q4 2024 earnings call?
Who will be presenting at MDxHealth's (MDXH) Q4 2024 earnings call?
Will there be a replay available for MDxHealth's (MDXH) Q4 2024 earnings call?
